중합효소 연쇄반응(PCR) 시장 : 제품, 기술, 용도, 최종 사용자별 - 세계 예측(2025-2030년)

The Polymerase Chain Reaction Market was valued at USD 9.08 billion in 2023, expected to reach USD 10.20 billion in 2024, and is projected to grow at a CAGR of 12.57%, to USD 20.82 billion by 2030.

Polymerase Chain Reaction (PCR) is a revolutionary technique in molecular biology that allows for the amplification of DNA sequences, making it indispensable in fields such as genomics, clinical diagnostics, forensic science, and biotechnology. The necessity of PCR arises from its ability to quickly and accurately detect and quantify nucleic acids in various samples, which is crucial in pathogen detection, genetic diseases, and research applications. The application and end-use scope of PCR are vast, ranging from clinical diagnostics and research institutions to agricultural biotechnology and environmental monitoring. Key growth factors in the PCR market include the increasing prevalence of infectious diseases and genetic disorders, advancements in PCR technologies such as digital PCR, and a rising demand for personalized medicine. Moreover, the pandemic has underscored the importance of robust diagnostic capabilities, further propelling PCR's market expansion. Emerging markets, especially in Asia-Pacific, represent significant opportunities due to their growing healthcare infrastructure and increasing research initiatives. However, the market faces challenges such as high equipment costs, stringent regulatory frameworks, and competitive pressure from alternative technologies like next-generation sequencing (NGS). Furthermore, there is an ongoing need for innovation in PCR technology, particularly in enhancing sensitivity, speed, and throughput. Developing more cost-effective, portable, and user-friendly PCR systems represents a promising area of research and business innovation. Additionally, integrating AI and bioinformatics tools for better data management and interpretation could provide competitive advantages. The nature of the PCR market is dynamic, with continuous advancements and a strong focus on research and development. Companies must remain agile and invest in cutting-edge technologies and strategic partnerships to capitalize on new opportunities. To overcome current limitations, focusing on continuous innovation, product diversification, and expanding application areas will be key to sustaining growth in the evolving PCR market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Polymerase Chain Reaction Market

The Polymerase Chain Reaction Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in the prevalence of infectious diseases, cancer, and genetic disease
  • Increasing life science and biopharmaceutical research and development activities
  • Growing demand in the food & beverage industry
• Market Restraints
  • High cost associated with a polymer chain reaction
• Market Opportunities
  • Introduction of high sensitive and optimized polymer chain reaction instruments
  • Technological advancements in molecular biology, life sciences, and biotechnology
• Market Challenges
  • Technical limitations of polymer chain reaction systems

Porter's Five Forces: A Strategic Tool for Navigating the Polymerase Chain Reaction Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Polymerase Chain Reaction Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Polymerase Chain Reaction Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Polymerase Chain Reaction Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Polymerase Chain Reaction Market

A detailed market share analysis in the Polymerase Chain Reaction Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Polymerase Chain Reaction Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Polymerase Chain Reaction Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Polymerase Chain Reaction Market

A strategic analysis of the Polymerase Chain Reaction Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Polymerase Chain Reaction Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 3M Company, Abbott Laboratories, ACON Laboratories, Inc., Agilent Technologies, Inc., Azure Biosystems Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux, S.A., Danaher Corporation, Eppendorf SE, F. Hoffmann-La Roche Ltd., Fluidigm Corporation, GeneCopoeia, Inc., Illumina, Inc., JN Medsys Pte. Ltd., Kawasaki Heavy Industries, Ltd., KYORIN Pharmaceutical Co., Ltd., LabTurbo Biotech Corporation, LGC Limited, MBS Molecular Biology Systems, Merck KGaA, Microsynth AG, Molbio Diagnostics Pvt. Ltd., Ningbo Scientz Biotechnology Co., Ltd., Promega Corporation, Shimadzu Corporation, Siemens AG, Standard BioTools, Stilla Technologies, Stilla Technologies Inc., SV SCIENTIFIC PRIVATE LIMITED, Sysmex AG, Takara Bio Inc., Thermo Fisher Scientific, Inc., and VWR International, LLC by Avantor, Inc..

Market Segmentation & Coverage

This research report categorizes the Polymerase Chain Reaction Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables & Reagents, Instruments, and Software & Services.
• Based on Technology, market is studied across Digital PCR, Real-time PCR, and Traditional PCR.
• Based on Application, market is studied across Medical and Non-Medical. The Medical is further studied across Clinical, Forensics, and Research. The Clinical is further studied across Blood screening, Oncology testing, and Pathology testing. The Non-Medical is further studied across Agriculture and Food.
• Based on End-User, market is studied across Academic Research Institutes, Biotechnology Companies, Contract Research Organization/ Contract Manufacturing Organization, Diagnostic Laboratories, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in the prevalence of infectious diseases, cancer, and genetic disease
    • 5.1.1.2. Increasing life science and biopharmaceutical research and development activities
    • 5.1.1.3. Growing demand in the food & beverage industry
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with a polymer chain reaction
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of high sensitive and optimized polymer chain reaction instruments
    • 5.1.3.2. Technological advancements in molecular biology, life sciences, and biotechnology
  • 5.1.4. Challenges
    • 5.1.4.1. Technical limitations of polymer chain reaction systems
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Polymerase Chain Reaction Market, by Product

• 6.1. Introduction
• 6.2. Consumables & Reagents
• 6.3. Instruments
• 6.4. Software & Services

7. Polymerase Chain Reaction Market, by Technology

• 7.1. Introduction
• 7.2. Digital PCR
• 7.3. Real-time PCR
• 7.4. Traditional PCR

8. Polymerase Chain Reaction Market, by Application

• 8.1. Introduction
• 8.2. Medical
  • 8.2.1. Clinical
    • 8.2.1.1. Blood screening
    • 8.2.1.2. Oncology testing
    • 8.2.1.3. Pathology testing
  • 8.2.2. Forensics
  • 8.2.3. Research
• 8.3. Non-Medical
  • 8.3.1. Agriculture
  • 8.3.2. Food

9. Polymerase Chain Reaction Market, by End-User

• 9.1. Introduction
• 9.2. Academic Research Institutes
• 9.3. Biotechnology Companies
• 9.4. Contract Research Organization/ Contract Manufacturing Organization
• 9.5. Diagnostic Laboratories
• 9.6. Hospitals

10. Americas Polymerase Chain Reaction Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Polymerase Chain Reaction Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Polymerase Chain Reaction Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Next Generation of qPCR Reagents push the boundaries of performance
  • 13.3.2. Mumbai-based Rivaara Labs raises funding from Amicus, Kotak investment advisors
  • 13.3.3. Roche introduces the cobas 5800, a new molecular diagnostic system to expand access to PCR testing in the U.S.
  • 13.3.4. Bosch's Vivalytic platform offering new PCR rapid test for MRSA
  • 13.3.5. Molbio Diagnostics raises $85 mn from Temasek at unicorn valuation
  • 13.3.6. Genomadix Inc. announces know-how license agreement with Mayo Clinic
  • 13.3.7. GenScript launches monkeypox PCR test
  • 13.3.8. Zymo Research to invest in Star Array for PCR platform development
  • 13.3.9. North York life sciences company gets $2.5M from provincial fund to help produce PCR test chemicals
  • 13.3.10. Roche expands the COVID-19 PCR test portfolio to the new cobas 5800 System in countries accepting the CE Mark
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. 3M Company
• 3. Abbott Laboratories
• 4. ACON Laboratories, Inc.
• 5. Agilent Technologies, Inc.
• 6. Azure Biosystems Inc.
• 7. Becton, Dickinson and Company
• 8. Bio-Rad Laboratories, Inc.
• 9. bioMerieux, S.A.
• 10. Danaher Corporation
• 11. Eppendorf SE
• 12. F. Hoffmann-La Roche Ltd.
• 13. Fluidigm Corporation
• 14. GeneCopoeia, Inc.
• 15. Illumina, Inc.
• 16. JN Medsys Pte. Ltd.
• 17. Kawasaki Heavy Industries, Ltd.
• 18. KYORIN Pharmaceutical Co., Ltd.
• 19. LabTurbo Biotech Corporation
• 20. LGC Limited
• 21. MBS Molecular Biology Systems
• 22. Merck KGaA
• 23. Microsynth AG
• 24. Molbio Diagnostics Pvt. Ltd.
• 25. Ningbo Scientz Biotechnology Co., Ltd.
• 26. Promega Corporation
• 27. Shimadzu Corporation
• 28. Siemens AG
• 29. Standard BioTools
• 30. Stilla Technologies
• 31. Stilla Technologies Inc.
• 32. SV SCIENTIFIC PRIVATE LIMITED
• 33. Sysmex AG
• 34. Takara Bio Inc.
• 35. Thermo Fisher Scientific, Inc.
• 36. VWR International, LLC by Avantor, Inc.